CA2404683A1 - Compositions of crosslinkable prepolymers for biodegradable implants - Google Patents
Compositions of crosslinkable prepolymers for biodegradable implants Download PDFInfo
- Publication number
- CA2404683A1 CA2404683A1 CA002404683A CA2404683A CA2404683A1 CA 2404683 A1 CA2404683 A1 CA 2404683A1 CA 002404683 A CA002404683 A CA 002404683A CA 2404683 A CA2404683 A CA 2404683A CA 2404683 A1 CA2404683 A1 CA 2404683A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- crosslinkable
- composition
- prepolymer
- biologically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
- C08F290/14—Polymers provided for in subclass C08G
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
- A61L2300/604—Biodegradation
Abstract
A composition suitable for preparing a biodegradable implant, comprising a crosslinkable multifunctional prepolymer having at least two polymerizable end groups, the said composition having a viscosity such that it is deformable at a temperature of 0° to 60 °C into a three-dimensional shape and being crosslinkable within the said temperature range. The prepolymer comprises a hydrophilic region and/or the composition further comprises an effective amount of a mineral biologically-active component delivery system and/or a biocompatible degradable porosity-inducing component.
Claims (31)
1. A composition suitable for preparing a biodegradable implant, comprising a crosslinkable multifunctional prepolymer having at least two polymerizable end groups, the said composition having a viscosity such that it is deformable at a temperature of 0° to 60°C into a three-dimensional shape and being crosslinkable within the said temperature range, wherein the said crosslinkable multifunctional prepolymer comprises a hydrophilic region.
2. A composition suitable for preparing a biodegradable implant, comprising a crosslinkable multifunctional prepolymer having at least two polymerizable end groups, the said composition having a viscosity such that it is deformable at a temperature of 0° to 60°C into a three-dimensional shape and being crosslinkable within the said temperature range, wherein the said composition further comprises an effective amount of a mineral biologically-active component delivery system.
3. A composition suitable for preparing a biodegradable implant, comprising a crosslinkable multifunctional prepolymer having at least two polymerizable end groups, the said composition having a viscosity such that it is deformable at a temperature of 0° to 60°C into a three-dimensional shape and being crosslinkable within the said temperature range, wherein the said composition further comprises an effective amount of a biocompatible degradable porosity-inducing component.
4. A composition according to any of claims 1 to 3, wherein the number average molecular weight of the said crosslinkable multifunctional prepolymer is in the range of 150 to 20,000.
5. A composition according to any of claims 1 to 4, wherein the said crosslinkable multifunctional prepolymer comprises at least one biodegradable region and at least one polymerizable region.
6. A composition according to claim 1, wherein the hydrophilic region of the said crosslinkable multifunctional prepolymer is a polyethylene glycol or a copolymer of ethylene oxide and an alkylene oxide with a degree of polymerization in the range of 2 to 500.
7. A composition according to claim 5, wherein the biodegradable region of the said crosslinkable multifunctional prepolymer is a predominantly amorphous region.
8. A composition according to any of claims 1 to 7, wherein the said crosslinkable multifunctional prepolymer comprises a polyacetal sequence.
9. A composition according to claim 2, wherein the said crosslinkable multifunctional prepolymer comprises a sequence which is able to generate acidic compounds.
10. A composition according to any of claims 1 to 9, wherein the said crosslinkable multifunctional prepolymer comprises a polyester sequence, resulting from copolymerizing a mixture of lactones wherein none of the lactone comonomers is present in the resulting polyester sequence in a molar proportion above 75%, or comprises a polyorthoester sequence or a combination of a polyester sequence and a polyorthoester sequence.
11. A composition according to claim 5, wherein the polymerizable region contains ethylenic and/or acetylenic unsaturations.
12. A composition according to any of claims 1 to 11, further comprising at least one additive selected from biocompatible unsaturated functional monomers and polymerization initiators including redox initiators or photoinitiators.
13. A composition according to claim 2 or claim 9, wherein the mineral biologically-active component delivery system is selected from demineralized bone, resorbable calcium phosphate-based particles, hydroxyapatite, tricalcium phosphate, octacalcium phosphate, calcium carbonate, calcium sulfate and coral.
14.A composition according to any of claims 2, 9 and 13, wherein the mineral biologically-active component delivery system is present in an amount able to increase the pH within the degrading polymer.
15.A composition according to any of claims 2, 9, 13 and 14, wherein the weight ratio mineral system:prepolymer is in the range from 0.05:1 to 20:1.
16. A composition according to any of claims 2, 9, 13 and 14, wherein the mineral biologically-active component delivery system is in the form of a powder.
17. A composition according to claim 3, wherein the biocompatible degradable porosity-inducing component is a monosaccharide, an oligosaccharide, a polysaccharide or a chemically-modified derivative thereof.
18. A composition according to claim 3, wherein the biocompatible degradable porosity-inducing component is a crosslinked gelatine.
19. A composition according to claim 3, wherein the biocompatible degradable porosity-inducing component is a synthetic polymeric porous particle.
20. A composition according to claim 3, wherein the weight ratio porosity-inducing component:prepolymer is in the range from 0.05:1 to 20:1.
21. A composition according to any of claims 1 to 19, further comprising a biologically-active component.
22. A composition according to claim 21, wherein the biologically-active component is selected from bone repair promoters, antimicrobial agents, proteins, peptides, hormones, carbohydrates, antineoplastic agents, antiangiogenic agents, vasoactive agents, anticoagulants, immunomodulators, cytotoxic agents, antiviral agents, antibodies, neurotransmitters, oligonucleotides, lipids, plasmids, DNA and diagnostic agents.
23. A composition according to claim 21, wherein the biologically-active component is a ligand with affinity for cells, or a chemically modified derivative thereof.
24. A composition according to claim 23, wherein the ligand is a protein selected from fibronectin, vitronectin and oligopeptides having from 3 to 25 amino-acids, or a chemically modified derivative thereof.
25. A composition according to claim 23, wherein the ligand or chemically modified derivative thereof is covalently anchored into the polymer matrix resulting from crosslinking of the functional prepolymer.
26. A composition according to any of claims 23 to 25, wherein the weight ratio ligand:prepolymer is in the range from 0.002:1 to 0.65:1.
27.A composition according to claim 3, further comprising a biologically-active component, wherein the said biocompatible degradable porosity-inducing component and the said biologically-active component are in proportions such that as to provide a synergistic effect in bone reconstruction.
28. Use of a composition according to any of claims 1 to 27 for the preparation of a therapeutically-active biodegradable implant.
29. Use according to claim 28, wherein the implant is a bone implant or a bone cement.
30. Use according to claim 28 for the fixation of a dental material or implant.
31. A method for repairing a bone defect by implanting a bone repair low viscosity formulation into the body of a mammal at a place suitable for bone growth and further crosslinking the said formulation, wherein the said formulation comprises a composition according to any of claims 1 to 27.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00201198A EP1142596A1 (en) | 2000-04-03 | 2000-04-03 | Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants |
EP00201198.9 | 2000-04-03 | ||
PCT/EP2001/003766 WO2001074411A1 (en) | 2000-04-03 | 2001-04-03 | Compositions of crosslinkable prepolymers for biodegradable implants |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2404683A1 true CA2404683A1 (en) | 2001-10-11 |
CA2404683C CA2404683C (en) | 2011-02-08 |
Family
ID=8171297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2404683A Expired - Fee Related CA2404683C (en) | 2000-04-03 | 2001-04-03 | Compositions of crosslinkable prepolymers for biodegradable implants |
Country Status (7)
Country | Link |
---|---|
US (1) | US6933328B2 (en) |
EP (2) | EP1142596A1 (en) |
AT (1) | ATE329630T1 (en) |
AU (2) | AU2001262159B2 (en) |
CA (1) | CA2404683C (en) |
DE (1) | DE60120660T2 (en) |
WO (1) | WO2001074411A1 (en) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6786915B2 (en) * | 2000-04-19 | 2004-09-07 | Radi Medical Systems Ab | Reinforced absorbable medical sealing device |
DE60131177T2 (en) * | 2000-09-06 | 2008-08-07 | AP Pharma, Inc., Redwood | DEVELOPABLE POLYACETAL POLYMERS |
DE60116799T2 (en) * | 2000-11-20 | 2006-09-28 | Matrix Innovation Inc. | PREPARATION AMPHIPHILER SOLID CARRIER FOR PEPTIDE SYNTHESIS AND BIOORGANIC AND ORGANIC CHEMISTRY |
AU2002245092A1 (en) * | 2000-12-08 | 2002-07-30 | Todd M. Boyce | Implant for orthopedic applications |
US6590059B2 (en) | 2001-05-11 | 2003-07-08 | Ap Pharma, Inc. | Bioerodible polyorthoesters from dioxolane-based diketene acetals |
AU2003215330B2 (en) | 2002-02-21 | 2008-03-13 | Encelle, Inc. | Immobilized bioactive hydrogel matrices as surface coatings |
US20080086792A1 (en) | 2006-10-13 | 2008-04-17 | Thomas Charles Kuracina | Method and apparatus for diverting sweat, liquid, moisture or the like from an eye |
US20040127563A1 (en) * | 2002-03-22 | 2004-07-01 | Deslauriers Richard J. | Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
EP2392359A3 (en) * | 2002-08-12 | 2012-03-07 | Warsaw Orthopedic, Inc. | Synthesis of a bone-polymer composite material |
CN100490900C (en) * | 2002-08-20 | 2009-05-27 | 精密技术公司 | Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition |
US7270813B2 (en) * | 2002-10-08 | 2007-09-18 | Osteotech, Inc. | Coupling agents for orthopedic biomaterials |
US20040152800A1 (en) * | 2002-10-09 | 2004-08-05 | Shalaby Shalaby W. | Photo-crosslinkable, crystalline, polyaxial, absorbable polyester for rapid prototyping |
US7045589B2 (en) | 2002-11-15 | 2006-05-16 | A.P. Pharma, Inc. | Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
WO2004053112A1 (en) * | 2002-12-12 | 2004-06-24 | Osteotech, Inc. | Formable and settable polymer bone composite and method of production thereof |
US7393493B2 (en) * | 2003-02-27 | 2008-07-01 | A Enterprises, Inc. | Crosslinkable polymeric materials and their applications |
US20060052471A1 (en) * | 2003-02-27 | 2006-03-09 | A Enterprises, Inc. | Initiators and crosslinkable polymeric materials |
DE10314082A1 (en) * | 2003-03-28 | 2004-10-21 | Mcs Micro Carrier Systems Gmbh | Biodegradable injectable implant |
US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
US7901457B2 (en) | 2003-05-16 | 2011-03-08 | Musculoskeletal Transplant Foundation | Cartilage allograft plug |
WO2005065079A2 (en) * | 2003-11-10 | 2005-07-21 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
EP1701672A4 (en) * | 2003-12-19 | 2011-04-27 | Osteotech Inc | Tissue-derived mesh for orthopedic regeneration |
US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
US20060015184A1 (en) * | 2004-01-30 | 2006-01-19 | John Winterbottom | Stacking implants for spinal fusion |
TW200533385A (en) * | 2004-03-03 | 2005-10-16 | Commw Scient Ind Res Org | Biocompatible polymer compositions for dual or multi staged curing |
CA2575740A1 (en) | 2004-03-24 | 2005-10-13 | Doctor's Research Group, Inc. | Methods of performing medical procedures that promote bone growth, methods of making compositions that promote bone growth, and apparatus for use in such methods |
DE602005020320D1 (en) * | 2004-06-16 | 2010-05-12 | Affinergy Inc | BORDER BIOMATERIALS FOR PROMOTING THE ATTACHMENT OF TARGET ANALYTES |
US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
FI122108B (en) * | 2004-11-17 | 2011-08-31 | Jvs Polymers Oy | Crosslinking biopolymer |
WO2006088866A2 (en) * | 2005-02-14 | 2006-08-24 | Indiana University Research And Technology Corporation | Biodegradable load-bearing carrier for bone regeneration |
AT501700B1 (en) * | 2005-04-14 | 2011-03-15 | Univ Wien Tech | RADIATION-CURABLE, BIODEGRADABLE COMPOSITIONS AND THEIR USE AS SUPPORTING MATERIALS FOR BONE REPLACEMENT |
CN101222902A (en) * | 2005-06-15 | 2008-07-16 | 苏尔莫迪克斯公司 | Macromer composition including light activated initiator |
US7815926B2 (en) | 2005-07-11 | 2010-10-19 | Musculoskeletal Transplant Foundation | Implant for articular cartilage repair |
WO2007048105A2 (en) * | 2005-10-19 | 2007-04-26 | A Enterprises, Inc. | Curable bone substitute |
WO2007065074A2 (en) * | 2005-11-29 | 2007-06-07 | Indiana University Research And Technology Corporation | Biodegradable implant polymers and composites |
EP1976459A4 (en) * | 2006-01-19 | 2012-06-20 | Warsaw Orthopedic Inc | Porous osteoimplant |
WO2007084725A2 (en) * | 2006-01-19 | 2007-07-26 | Osteotech, Inc. | Injectable and moldable bone substitute materials |
WO2007124537A1 (en) * | 2006-04-27 | 2007-11-08 | Queensland University Of Technology | Biodegradable implants for bone fusion and compositions therefor |
EP2044142A2 (en) | 2006-06-29 | 2009-04-08 | Medtronic, Inc. | Poly(orthoester) polymers, and methods of making and using same |
GB0618963D0 (en) * | 2006-09-26 | 2006-11-08 | Ucl Business Plc | Formulations and composites with reactive fillers |
US8435551B2 (en) | 2007-03-06 | 2013-05-07 | Musculoskeletal Transplant Foundation | Cancellous construct with support ring for repair of osteochondral defects |
AT506168B1 (en) * | 2007-11-23 | 2012-02-15 | Univ Wien Tech | USE OF COMPOSITIONS FOR THE MANUFACTURE OF BIODEGRADABLE, BIOVEROUS, NETWORKED POLYMERS BASED ON POLYVINYL ALCOHOL |
EP2428235B1 (en) * | 2007-11-23 | 2014-06-04 | Technische Universität Wien | Use of compounds hardened by means of polymerisation for producing biodegradable, biocompatible, networked polymers |
WO2009111069A1 (en) | 2008-03-05 | 2009-09-11 | Musculoskeletal Transplant Foundation | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
DE102008018905A1 (en) | 2008-04-14 | 2009-10-15 | Philipps-Universität Marburg | Polyionic copolymer, which is made of cyclic ketene acetal e.g. 2-methylen-1,3-dioxepan, methacrylic acid derivative e.g. 2-methyl-methacryalte compound and methacrylic acid derivative e.g. acrylonitrile, useful e.g. as adhesives |
DE102008028146A1 (en) | 2008-06-14 | 2009-12-17 | Philipps-Universität Marburg | Hydrolytically-degradable polyionic copolymers from cyclic ketene acetals and methacrylic acid derivatives with ionic groups, used e.g. for production of nano-particles and in adhesives or drug-release applications |
US9068065B2 (en) | 2008-04-14 | 2015-06-30 | Basf Se | Hydrolytically decomposable ionic copolymers |
US8956642B2 (en) | 2008-04-18 | 2015-02-17 | Medtronic, Inc. | Bupivacaine formulation in a polyorthoester carrier |
US8475823B2 (en) | 2008-04-18 | 2013-07-02 | Medtronic, Inc. | Baclofen formulation in a polyorthoester carrier |
WO2009152276A2 (en) | 2008-06-10 | 2009-12-17 | University Of North Carolina At Charlotte | Photoacid generators and lithographic resists comprising the same |
US20120207847A1 (en) * | 2009-08-25 | 2012-08-16 | Genzyme Corporation | Cartilage Repair |
WO2011147452A1 (en) * | 2010-05-26 | 2011-12-01 | Universiteit Twente | Method for preparing a degradable polymer network |
WO2015095745A1 (en) | 2010-10-20 | 2015-06-25 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
US20120101593A1 (en) | 2010-10-20 | 2012-04-26 | BIOS2 Medical, Inc. | Implantable polymer for bone and vascular lesions |
US11484627B2 (en) | 2010-10-20 | 2022-11-01 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
US9320601B2 (en) | 2011-10-20 | 2016-04-26 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
US11058796B2 (en) | 2010-10-20 | 2021-07-13 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
US10525169B2 (en) | 2010-10-20 | 2020-01-07 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
US11207109B2 (en) | 2010-10-20 | 2021-12-28 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications |
US11291483B2 (en) | 2010-10-20 | 2022-04-05 | 206 Ortho, Inc. | Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants |
CN102120817A (en) * | 2011-01-11 | 2011-07-13 | 同济大学 | Crosslinking polylactic acid and preparation method thereof |
US20120219629A1 (en) * | 2011-02-25 | 2012-08-30 | Empire Technology Development Llc | Compositions and methods for controlled delivery of compounds |
CA2854160A1 (en) | 2011-11-02 | 2013-05-10 | Halscion, Inc. | Methods and compositions for wound treatment |
US9498335B2 (en) * | 2012-10-02 | 2016-11-22 | Seth McCullen | Implantable devices for musculoskeletal repair and regeneration |
EP2907834A4 (en) * | 2012-10-09 | 2015-09-30 | Shanghai Microport Medical Group Co Ltd | Biodegradable cross-linked polymer, vascular stent and manufacturing methods therefor |
EP2999747B1 (en) | 2013-05-23 | 2020-08-12 | 206 ORTHO, Inc. | Apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone |
EP3200728B1 (en) | 2014-10-02 | 2019-08-07 | McCullen, Seth | Anatomically designed meniscus implantable devices |
CN105818492B (en) * | 2016-03-29 | 2018-02-16 | 中材科技股份有限公司 | A kind of bioactivity phosphate base continuous glass fibre composite material for weaving and application thereof |
US11452606B2 (en) | 2017-05-02 | 2022-09-27 | Orthonika Limited | Composite joint implant |
US11331854B2 (en) * | 2018-03-26 | 2022-05-17 | Arevo, Inc. | System and method for dispensing composite filaments for additive manufacturing |
US20220125996A1 (en) * | 2019-01-15 | 2022-04-28 | University Of Massachusetts | Eggshell Particle Containing Hydrogels And Prepolymer Compositions For Biomedical Applications |
GB201910895D0 (en) * | 2019-07-31 | 2019-09-11 | Univ Birmingham | Curable monomers and compositions |
CN111067670B (en) * | 2019-12-24 | 2022-10-14 | 北京壹点灵动科技有限公司 | Acetabular bone defect assessment method and device and electronic equipment |
JP2021191810A (en) * | 2020-06-05 | 2021-12-16 | 日清紡ホールディングス株式会社 | Marine biodegradation accelerator |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5085861A (en) * | 1987-03-12 | 1992-02-04 | The Beth Israel Hospital Association | Bioerodable implant composition comprising crosslinked biodegradable polyesters |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5108755A (en) * | 1989-04-27 | 1992-04-28 | Sri International | Biodegradable composites for internal medical use |
US5410016A (en) * | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
JPH09511666A (en) * | 1994-04-08 | 1997-11-25 | アトリックス・ラボラトリーズ・インコーポレイテッド | Ancillary polymer systems for use in medical devices |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
US5703200A (en) * | 1996-03-15 | 1997-12-30 | Ethicon, Inc. | Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer |
ZA978537B (en) * | 1996-09-23 | 1998-05-12 | Focal Inc | Polymerizable biodegradable polymers including carbonate or dioxanone linkages. |
US5837752A (en) * | 1997-07-17 | 1998-11-17 | Massachusetts Institute Of Technology | Semi-interpenetrating polymer networks |
ATE275977T1 (en) * | 1998-04-13 | 2004-10-15 | Massachusetts Inst Technology | COMB POLYMERS FOR REGULATING CELL SURFACE INTERACTION |
US6171610B1 (en) * | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
ATE514729T1 (en) | 1999-02-01 | 2011-07-15 | Eidgenoess Tech Hochschule | BIOMATERIALS ADDED BY NUCLEOPHILIC REACTION ON CONJUGATE UNSATURATED GROUPS |
ATE275986T1 (en) | 2000-05-31 | 2004-10-15 | Mnemoscience Gmbh | MEMORY THERMOPLASTIC AND POLYMER NETWORKS FOR TISSUE CONSTRUCTION |
-
2000
- 2000-04-03 EP EP00201198A patent/EP1142596A1/en not_active Withdrawn
-
2001
- 2001-04-03 EP EP01936174A patent/EP1267953B1/en not_active Expired - Lifetime
- 2001-04-03 AU AU2001262159A patent/AU2001262159B2/en not_active Ceased
- 2001-04-03 WO PCT/EP2001/003766 patent/WO2001074411A1/en active IP Right Grant
- 2001-04-03 AU AU6215901A patent/AU6215901A/en active Pending
- 2001-04-03 DE DE60120660T patent/DE60120660T2/en not_active Expired - Lifetime
- 2001-04-03 CA CA2404683A patent/CA2404683C/en not_active Expired - Fee Related
- 2001-04-03 US US10/239,623 patent/US6933328B2/en not_active Expired - Fee Related
- 2001-04-03 AT AT01936174T patent/ATE329630T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60120660T2 (en) | 2007-06-14 |
WO2001074411A1 (en) | 2001-10-11 |
US6933328B2 (en) | 2005-08-23 |
EP1267953B1 (en) | 2006-06-14 |
US20030114552A1 (en) | 2003-06-19 |
CA2404683C (en) | 2011-02-08 |
DE60120660D1 (en) | 2006-07-27 |
EP1267953A1 (en) | 2003-01-02 |
AU2001262159B2 (en) | 2005-07-14 |
AU6215901A (en) | 2001-10-15 |
EP1142596A1 (en) | 2001-10-10 |
ATE329630T1 (en) | 2006-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2404683A1 (en) | Compositions of crosslinkable prepolymers for biodegradable implants | |
EP1729830B1 (en) | Process for manufacturing an implantable gel | |
US7621963B2 (en) | Composite bone graft material | |
Wise | Encyclopedic handbook of biomaterials and bioengineering: v. 1-2. Applications | |
Bongio et al. | Development of bone substitute materials: from ‘biocompatible’to ‘instructive’ | |
US5273964A (en) | Inorganic and organic composition for treatment of bone lesions | |
DK2403547T3 (en) | MANUFACTURING FORMABLE BONE COMPENSATION | |
US20030055512A1 (en) | Calcium based neutral and bioresorbable bone graft | |
Lee et al. | Hydroxyapatite-containing gelatin/chitosan microspheres for controlled release of lysozyme and enhanced cytocompatibility | |
AU2011239742B2 (en) | Biomaterial | |
US20060198863A1 (en) | Ceramic composition for filling bone defects | |
Watson et al. | Phosphorous-containing polymers for regenerative medicine | |
Hamdy | Polymers and ceramics biomaterials in orthopedics and dentistry: a review article | |
Vezenkova et al. | Sudoku of porous, injectable calcium phosphate cements–Path to osteoinductivity | |
US20060233849A1 (en) | Composite bone graft material | |
Victor et al. | Polymer ceramic composite materials for orthopedic applications—relevance and need for mechanical match and bone regeneration | |
AU6127400A (en) | Composites | |
CA2516728C (en) | Biodegradable bone implant material | |
CN113750289A (en) | Organic-inorganic composite bioactive material based on calcium phosphate and preparation method thereof | |
Pan et al. | Assessment of the suitability of a new composite as a bone defect filler in a rabbit model | |
Rödel | Development of Dual Setting Cement Systems as Composite Biomaterials with Ductile Properties | |
Stancu et al. | Developments in Hydrogel‐based Scaffolds and Bioceramics for Bone Regeneration | |
CN101601643A (en) | A kind of skeleton hemostasis gel | |
Gkioni et al. | Biodegradable polymeric/ceramic composite scaffolds to regenerate bone tissue | |
Dorozhkin | Biocomposites and Hybrid Biomaterials of Calcium Orthophosphates with Polymers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140403 |